Vancouver, British Columbia–(Newsfile Corp. – October 10, 2025) – NexMetals Mining Corp. (TSXV: NEXM) (NASDAQ: NEXM) (the “Company“) announces that it has continued out of the provincial jurisdiction of Ontario into the jurisdiction of the Province of British Columbia under the Business Corporations Act (British Columbia) (the “BCBCA“). Shareholders approved …
Read More »Zedge to Present at The LD Micro Main Event XIX on October 20, 2025
New York, New York–(Newsfile Corp. – October 10, 2025) – Zedge, Inc. (NYSE American: ZDGE), $ZDGE, a leader in digital marketplaces and interactive games that provide content, enable creativity, empower self-expression and facilitate community, announced today that CEO Jonathan Reich will be presenting at the LD Micro Main Event XIX …
Read More »Intrepid Metals Announces 4-Month Hold Private Placement Financing
Vancouver, British Columbia–(Newsfile Corp. – October 10, 2025) – Intrepid Metals Corp. (TSXV: INTR) (OTCQB: IMTCF) (“Intrepid” or the “Company”) announces a non-brokered private placement (the “Offering“) consisting of up to 17,142,857 units (the “Units“), with each Unit consisting of one common share and one-half of one common share purchase …
Read More »Gunnison Copper Announces Private Placement for Gross Proceeds of up to C$15.0 Million
Phoenix, Arizona–(Newsfile Corp. – October 10, 2025) – Gunnison Copper Corp. (TSX: GCU) (OTCQB: GCUMF) (FSE: 3XS0) (“Gunnison” or the “Company”) is pleased to announce a non-brokered private placement (the “Offering“) for gross proceeds of up to C$15 million from the sale of up to 33,333,333 units of the Company …
Read More »TempraMed Receives Final Receipt for Prospectus and Closes Reverse Takeover Transaction of TempraMed Israel
Vancouver, British Columbia–(Newsfile Corp. – October 10, 2025) – TempraMed Technologies Ltd. (the “Company“) is pleased to announce that the Company has filed and obtained a receipt on September 29, 2025, for its final long form prospectus dated September 25, 2025 (the “Prospectus“), with the British Columbia Securities Commission and …
Read More »Scandium International Mining Announces Grant of New Mining Lease at Nyngan Scandium Project
Reno, Nevada–(Newsfile Corp. – October 10, 2025) – Scandium International Mining Corp. (TSXV: SCY) (OTC Pink: SCYYF) (“Scandium International” or the “Company“) is pleased to announce that the Department of Primary Industrials and Regional Development – NSW Resources (“the Department“) has granted a mining license to Scandium International’s wholly-owned subsidiary, …
Read More »St. Augustine Gold and Copper Limited Advances Kingking Project to Definitive Feasibility Study and Engages Consulting Engineering Firms
Manila, Philippines–(Newsfile Corp. – October 10, 2025) – St. Augustine Gold and Copper Limited (TSX: SAU) (“St. Augustine” or the “Company”) is pleased to announce the engagement of Stantec Consulting Ltd. (“Stantec”) and Independent Mining Consultants, Inc. (“IMC”) to complete a Definitive Feasibility Study (DFS) for the Kingking Copper-Gold Project …
Read More »StrategX Issues Shares in Settlement of Debt
Vancouver, British Columbia–(Newsfile Corp. – October 10, 2025) – StrategX Elements Corp. (CSE: STGX) (“StrategX” or the “Company“) announces that further to its news release of October 3, 2025, it has now issued an aggregate of 2,342,304 common shares at a deemed price of $0.18 per share to settle aggregate …
Read More »Search Minerals Announces Amended Terms for Non-Brokered Private Placement Financings
St. Lewis, Newfoundland and Labrador–(Newsfile Corp. – October 10, 2025) – Search Minerals Inc. (TSXV: SMY) (“Search Minerals” or the “Company“) is pleased to announce that it has amended the terms of its previously announced non-brokered private placement financings for gross proceeds of up to $993,847. Under the amended terms …
Read More »OS Therapies Announces Statistically Significant Positive Final 2-Year Overall Survival Data from Phase 2b Trial of OST-HER2 in the Prevention or Delay of Recurrent, Fully-Resected, Pulmonary Metastatic Osteosarcoma
75% of OST-HER2 treated patients achieved 2-year overall survival compared with 40% in the historical control group (p < 0.0001) 100% of patients who achieved 12 month event free survival achieved 2 year overall survival New York, New York–(Newsfile Corp. – October 10, 2025) – OS Therapies Inc. (NYSE American: …
Read More »
Matribhumi Samachar English